Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -37.34M | -346.83% | $ 10.77M |
3/31/2025 | $ -47.56M | -238.22% | $ 19.96M |
12/31/2024 | $ -59.92M | -305.2% | $ 19.63M |
9/30/2024 | $ -67.66M | -333.84% | $ 20.27M |
6/30/2024 | $ -75.64M | -365.24% | $ 20.71M |
3/31/2024 | $ -78.07M | -517.93% | $ 15.07M |
12/31/2023 | $ -81.18M | -544.12% | $ 14.92M |
9/30/2023 | $ -62.4M | -587.01% | $ 10.63M |
6/30/2023 | $ -17.75M | -37.91% | $ 46.8M |
3/31/2023 | $ -7.79M | -18.02% | $ 43.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for CARISMA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -36.13M ] / Revenues [ $ 11.24M ]
(=) OCF % [ -321.58% ]
Minimum
Sep 30, 2021
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.33% |
median | 12.67% |
std | 21.12% |